J&J Defends Win In Second Ovarian Cancer Bellwether Trial In Los Angeles

( August 20, 2026, 1:00 PM EDT) -- LOS ANGELES — Johnson & Johnson (J&J) and an affiliate told the California judge who oversaw the second bellwether asbestos-talc ovarian cancer trial that the jury heard sufficient evidence about the companies’ testing and marketing efforts to support its findings on negligence and negligence per se claims and that a new trial is not warranted....